Activation and Regulation of Cellular Inflammasomes: Gaps in Our Knowledge for Central Nervous System Injury

[1]  G. Dahl,et al.  Pyroptotic Neuronal Cell Death Mediated by the AIM2 Inflammasome , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Si Ming Man,et al.  Salmonella Infection Induces Recruitment of Caspase-8 to the Inflammasome To Modulate IL-1β Production , 2013, The Journal of Immunology.

[3]  A. Mortellaro,et al.  Caspase‐11: The driving factor for noncanonical inflammasomes , 2013, European journal of immunology.

[4]  Deming Zhao,et al.  Inhibition of phagocytosis and lysosomal acidification suppresses neurotoxic prion peptide-induced NALP3 inflammasome activation in BV2 microglia , 2013, Journal of Neuroimmunology.

[5]  Juan Pablo Rivero Vaccari,et al.  Human astrocytes express a novel NLRP2 inflammasome , 2013, Glia.

[6]  J. Kuemmerle-Deschner,et al.  Inflammasome and cytokine blocking strategies in autoinflammatory disorders. , 2013, Clinical immunology.

[7]  E. Latz,et al.  Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.

[8]  L. Tan,et al.  The NLRP3 Inflammasome in Alzheimer’s Disease , 2013, Molecular Neurobiology.

[9]  Xiaozheng Xu,et al.  Gene Deletion of Gabarap Enhances Nlrp3 Inflammasome-Dependent Inflammatory Responses , 2013, The Journal of Immunology.

[10]  A. Charollais,et al.  Promises and pitfalls of a Pannexin1 transgenic mouse line , 2013, Front. Pharmacol..

[11]  E. Lien,et al.  Inflammasomes and host defenses against bacterial infections. , 2013, Current opinion in microbiology.

[12]  K. J. Henley,et al.  NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. , 2012, Immunity.

[13]  G. Dahl,et al.  Pannexin: From discovery to bedside in 11±4 years? , 2012, Brain Research.

[14]  J. P. de Rivero Vaccari,et al.  Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. , 2012, Journal of neurosurgery.

[15]  D. Ojcius,et al.  Alarmins, inflammasomes and immunity. , 2012, Biomedical journal.

[16]  L. Bernier.  Purinergic regulation of inflammasome activation after central nervous system injury , 2012, The Journal of general physiology.

[17]  H. Bramlett,et al.  Effects of Therapeutic Hypothermia on Inflammasome Signaling after Traumatic Brain Injury , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  M. Lotze,et al.  PAMPs and DAMPs: signal 0s that spur autophagy and immunity , 2012, Immunological reviews.

[19]  K. Tracey,et al.  Novel role of PKR in inflammasome activation and HMGB1 release , 2012, Nature.

[20]  J. Bertin,et al.  Autolytic Proteolysis within the Function to Find Domain (FIIND) Is Required for NLRP1 Inflammasome Activity* , 2012, The Journal of Biological Chemistry.

[21]  S. Leppla,et al.  Anthrax Lethal Factor Cleavage of Nlrp1 Is Required for Activation of the Inflammasome , 2012, PLoS pathogens.

[22]  Y. de Koninck,et al.  P2X4 Receptors Influence Inflammasome Activation after Spinal Cord Injury , 2012, The Journal of Neuroscience.

[23]  D. Golenbock,et al.  Activation of the NLRP3 Inflammasome by Group B Streptococci , 2012, The Journal of Immunology.

[24]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis , 2012, European journal of immunology.

[25]  N. Suttorp,et al.  Rac1 Regulates the NLRP3 Inflammasome Which Mediates IL-1beta Production in Chlamydophila pneumoniae Infected Human Mononuclear Cells , 2012, PloS one.

[26]  John Calvin Reed,et al.  NLRP1, a regulator of innate immunity associated with vitiligo , 2012, Pigment cell & melanoma research.

[27]  H. Monyer,et al.  Pannexins in ischemia-induced neurodegeneration , 2011, Proceedings of the National Academy of Sciences.

[28]  H. Bramlett,et al.  Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats , 2011, BMC Neuroscience.

[29]  M. Wittmann,et al.  Human keratinocytes express AIM2 and respond to dsDNA with IL‐1β secretion , 2011, Experimental dermatology.

[30]  T. Kielian,et al.  Inflammasome activation and IL‐1β/IL‐18 processing are influenced by distinct pathways in microglia , 2011, Journal of neurochemistry.

[31]  D. Monack,et al.  Elevated AIM2‐mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis , 2011, Cellular microbiology.

[32]  J. Velíšková,et al.  Targeting Pannexin1 Improves Seizure Outcome , 2011, PloS one.

[33]  A. Aderem,et al.  Caspase‐1‐induced pyroptotic cell death , 2011, Immunological reviews.

[34]  R. Flavell,et al.  NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy , 2011, Proceedings of the National Academy of Sciences.

[35]  V. Hornung,et al.  Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions , 2011, Science Translational Medicine.

[36]  S. Young,et al.  Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. , 2011, Cell metabolism.

[37]  A. Aderem,et al.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria , 2010, Nature Immunology.

[38]  B. Ryffel,et al.  Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. , 2010, American journal of respiratory and critical care medicine.

[39]  J. Tschopp,et al.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome , 2010, Gut.

[40]  Eva Szomolanyi-Tsuda,et al.  The AIM2 inflammasome is essential for host-defense against cytosolic bacteria and DNA viruses , 2010, Nature Immunology.

[41]  Yuchun Luo,et al.  Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β* , 2009, The Journal of Biological Chemistry.

[42]  V. Dixit,et al.  Glyburide inhibits the Cryopyrin/Nalp3 inflammasome , 2009, The Journal of cell biology.

[43]  J. B. Garrison,et al.  XIAP mediates NOD signaling via interaction with RIP2 , 2009, Proceedings of the National Academy of Sciences.

[44]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[45]  G. Núñez,et al.  Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1 , 2009, The Journal of Immunology.

[46]  J. P. de Rivero Vaccari,et al.  The Pannexin 1 Channel Activates the Inflammasome in Neurons and Astrocytes* , 2009, The Journal of Biological Chemistry.

[47]  H. Bramlett,et al.  Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  G. Superti-Furga,et al.  An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome , 2009, Nature Immunology.

[49]  J. P. de Rivero Vaccari,et al.  Inhibition of the Inflammasome Complex Reduces the Inflammatory Response after Thromboembolic Stroke in Mice , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  G. Dahl,et al.  A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. , 2009, American journal of physiology. Cell physiology.

[51]  E. Alnemri,et al.  AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA , 2009, Nature.

[52]  Daniel R. Caffrey,et al.  AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC , 2009, Nature.

[53]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[54]  V. Nizet,et al.  A NOD2–NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide , 2008, Proceedings of the National Academy of Sciences.

[55]  J. P. de Rivero Vaccari,et al.  A Molecular Platform in Neurons Regulates Inflammation after Spinal Cord Injury , 2008, The Journal of Neuroscience.

[56]  G. Núñez,et al.  Pannexin-1-Mediated Intracellular Delivery of Muramyl Dipeptide Induces Caspase-1 Activation via Cryopyrin/NLRP3 Independently of Nod21 , 2008, The Journal of Immunology.

[57]  J. Fernández-Luna,et al.  NLRP2, an Inhibitor of the NF-κB Pathway, Is Transcriptionally Activated by NF-κB and Exhibits a Nonfunctional Allelic Variant1 , 2007, The Journal of Immunology.

[58]  F. Martinon,et al.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.

[59]  F. Di Virgilio,et al.  Liaisons dangereuses: P2X(7) and the inflammasome. , 2007, Trends in pharmacological sciences.

[60]  G. Dubyak,et al.  Differential Requirement of P2X7 Receptor and Intracellular K+ for Caspase-1 Activation Induced by Intracellular and Extracellular Bacteria* , 2007, Journal of Biological Chemistry.

[61]  F. Martinon,et al.  Inflammasome Components NALP 1 and 3 Show Distinct but Separate Expression Profiles in Human Tissues Suggesting a Site-specific Role in the Inflammatory Response , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[62]  A. Osterman,et al.  Bcl-2 and Bcl-XL Regulate Proinflammatory Caspase-1 Activation by Interaction with NALP1 , 2007, Cell.

[63]  J. Ting,et al.  Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functions. , 2007, Microbes and infection.

[64]  N. Volkmann,et al.  Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. , 2007, Molecular cell.

[65]  D. Spray,et al.  Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex , 2007, FEBS letters.

[66]  M. Bianchi.  DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[67]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[68]  W. Dietrich,et al.  Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin , 2006, Nature Genetics.

[69]  G. Dahl,et al.  Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium , 2006, FEBS letters.

[70]  J. Ting,et al.  CATERPILLER 16.2 (CLR16.2), a Novel NBD/LRR Family Member That Negatively Regulates T Cell Function* , 2005, Journal of Biological Chemistry.

[71]  Christian Stehlik,et al.  PAN1/NALP2/PYPAF2, an Inducible Inflammatory Mediator That Regulates NF-κB and Caspase-1 Activation in Macrophages* , 2004, Journal of Biological Chemistry.

[72]  F. Martinon,et al.  Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome , 2004, Current Biology.

[73]  F. Martinon,et al.  Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.

[74]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[75]  J C Reed,et al.  Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.

[76]  Yan A. Su,et al.  Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma , 1997, Oncogene.

[77]  G. Burnstock,et al.  ATP-stimulated release of ATP by human endothelial cells. , 1996, Journal of cardiovascular pharmacology.

[78]  R. North,et al.  Pharmacology of cloned P2X receptors. , 2000, Annual review of pharmacology and toxicology.